Financing
Financing Cash Flow
Year-over-year, this metric grew by 45.4%, from -$5.23B to -$2.86B. Over 4 years (FY 2021 to FY 2025), Financing Cash Flow shows a downward trend with a 2.7% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
A large negative value typically indicates a company is returning capital to shareholders or paying down debt, while a positive value suggests the company is raising external capital to fund operations or acquisitions.
Detailed definition
This metric represents the net flow of cash between a company and its capital providers, including shareholders and lend...
Peer comparison
Large-cap peers like Microsoft or Alphabet similarly show large negative financing outflows due to aggressive share repurchase programs and dividend distributions.
Metric ID:
net_cash_from_financingHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.56B | -$1.10B | -$3.35B | -$6.58B | $2.52B | -$5.76B | -$5.02B | -$2.77B | $27.17B | -$3.78B | $5.44B | -$4.93B | -$2.46B | -$4.64B | -$5.11B | -$5.23B | -$3.20B | -$2.48B | $0.00 | -$2.86B |
| QoQ Change | — | +56.9% | -204.4% | -96.3% | +138.3% | -328.6% | +12.9% | +44.7% | >999% | -113.9% | +244.0% | -190.6% | +50.1% | -88.5% | -10.3% | -2.2% | +38.9% | +22.5% | +100.0% | — |
| YoY Change | — | — | — | — | +198.6% | -423.3% | -49.7% | +57.9% | +978.3% | +34.4% | +208.5% | -78.0% | -109.0% | -22.7% | -194.0% | -6.0% | -30.0% | +46.6% | +100.0% | +45.4% |
Range-$6.58B – $27.17B
CAGR+2.4%
Avg YoY Growth+47.3%
Median YoY Growth+14.2%
Current Streak4 quarters growth
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is Pfizer's financing cash flow?
- Pfizer (PFE) reported financing cash flow of -$2.86B in Q1 2026.
- How has Pfizer's financing cash flow changed year-over-year?
- Pfizer's financing cash flow increased by 45.4% year-over-year, from -$5.23B to -$2.86B.
- What is the long-term trend for Pfizer's financing cash flow?
- Over 4 years (2021 to 2025), Pfizer's financing cash flow has grown at a 2.7% compound annual growth rate (CAGR), from -$9.82B to -$10.90B.
- What does financing cash flow mean?
- The total amount of money a company spends or receives from borrowing debt and managing its own shares and dividends.